Clinical Trials Logo

Filter by:
NCT ID: NCT04567719 Active, not recruiting - Bladder Cancer Clinical Trials

Measuring Taste Perception During Chemotherapy for Muscle Invasive Bladder Cancer

Start date: March 3, 2020
Phase:
Study type: Observational

Alteration in the sense of taste is a frequent symptom that is closely linked to chemotherapy exposure, lowering quality of life and nutritional status. Malnutrition is of particular concern in muscle-invasive bladder cancer (MIBC), as malnutrition is associated with many negative outcomes from radical cystectomy (the surgical procedure in MIBC), which include higher morbidity, poor wound healing, and higher rate of infections after surgery. It is essential to understand taste changes among participants receiving chemotherapy for MIBC to create future treatment trials.

NCT ID: NCT04567680 Active, not recruiting - Clinical trials for Post-traumatic Stress Disorder

Acceptance and Commitment Therapy to Improve Social Support for Veterans With PTSD

ACT-SS
Start date: March 1, 2021
Phase: N/A
Study type: Interventional

Veterans with PTSD often have impaired social relationships and poor social support. The negative outcomes associated with poor social support are of particular concern for Veterans with PTSD, who often perceive the world to be dangerous, view their social support network as a threat to their safety, and avoid members of their support network in order to increase their perceived safety. The goal of this project is to evaluate the efficacy of Acceptance and Commitment Therapy to Improve Social Support for Veterans with PTSD (ACT-SS), a treatment focused on helping Veterans with PTSD to increase social support with family relationships, partners, and peers by targeting maladaptive patterns of interpersonal difficulties, feelings of detachment from others, irritability, and avoidance of social situations. The primary aim of this study is to conduct a two-site randomized controlled trial of ACT-SS (n=75) vs. PCT (n=75), a common treatment for social support difficulties. If positive, this study will provide a critically-needed treatment for Veterans with PTSD to improve their social functioning and social reintegration in the community.

NCT ID: NCT04567537 Active, not recruiting - Scleroderma Clinical Trials

Laser Treatment for the Improvement of Scars and Scleroderma

Start date: June 2, 2021
Phase: N/A
Study type: Interventional

In this study, the investigators seek to evaluate the effects of a laser treatment on the redistribution/regeneration of collagen on the clinical, microscopic, and molecular profiles of hypertrophic scars and scleroderma.

NCT ID: NCT04567394 Active, not recruiting - Clinical trials for Cannabis Use Disorder, Moderate

Cannabis Use Disorder Treatment Study

Start date: December 7, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to test a text-delivered counseling program to stop or reduce cannabis use among young adults (ages 18 to 25).

NCT ID: NCT04567043 Active, not recruiting - Chronic Pain Clinical Trials

Treating Opioid Misuse Via Mindfulness-Based Just-in-Time Adaptive Intervention

MORE-JITAI
Start date: September 24, 2020
Phase: N/A
Study type: Interventional

This pilot RCT will examine the preliminary efficacy of a telehealth version of Mindfulness-Oriented Recovery Enhancement (MORE) enriched with a smartphone-based just-in-time adaptive intervention (JITAI) for patients with chronic pain on long-term opioid therapy.

NCT ID: NCT04566978 Active, not recruiting - DLBCL Clinical Trials

89Zr-DFO-REGN3767 in PET Scans in People With Diffuse Large B Cell Lymphoma (DLBCL)

Start date: September 11, 2020
Phase: Early Phase 1
Study type: Interventional

The main purposes of this study include: Looking at the way the body absorbs, distributes, and gets rid of 89Zr-DFO-REGN3767 Finding the best dose amount of 89Zr-DFO-REGN3767 Finding the best time for PET scanning after injection of 89Zr-DFO-REGN3767

NCT ID: NCT04566445 Active, not recruiting - Clinical trials for Dry Age-related Macular Degeneration

HORIZON: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005

Start date: September 28, 2020
Phase: Phase 2
Study type: Interventional

The purpose of this clinical study is to evaluate the safety and efficacy of two doses of GT005 administered as a single subretinal injection in subjects with geographic atrophy secondary to age-related macular degeneration (AMD).

NCT ID: NCT04566055 Active, not recruiting - Clinical trials for Kidney Transplant Rejection

Assessing AlloSure Dd-cfDNA Monitoring Insights of Renal Allografts With Longitudinal Surveillance

ADMIRAL
Start date: March 1, 2019
Phase:
Study type: Observational [Patient Registry]

Prospective Observational Multicenter Cohort. External validation of donor derived cell free DNA in Renal Transplantation. Assessing performance of dd-cfDNA as a surveillance tool and its association with clinical outcomes. Outcomes include formation of de-novo DSA, eGFR decline, performance of AlloSure dd-cfDNA in Allograft rejection.

NCT ID: NCT04565899 Active, not recruiting - Clinical trials for Alcohol Use Disorder

Improving Care for Unhealthy Alcohol Use in Primary Care

Start date: February 25, 2021
Phase: N/A
Study type: Interventional

In order to improve the quality of alcohol-related care for those with unhealthy alcohol use, the current research will use an evidence-based implementation strategy, practice facilitation, at one VA primary care site to pilot test whether practice facilitation has the potential to improve the quality of primary care-based alcohol-related care . It is hypothesized that primary care providers who take part in the practice facilitation intervention will provide higher quality substance use care to Veterans with unhealthy alcohol use compared to care pre-practice facilitation (e.g., administer evidence-based brief counseling interventions at higher rates, prescribe alcohol use disorder pharmacotherapy at higher rates, increase referrals to specialty substance use disorder clinics).

NCT ID: NCT04565821 Active, not recruiting - Crohn Disease Clinical Trials

Feasibility Study to Assess a Trans-nasal Intestinal Potential Difference Probe

Start date: November 12, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to examine the feasibility of using a trans-nasal IPD probe as a measurement tool for gut permeability